美股盘前丨股指期货走低 Arcellx盘前涨超78%
Xin Lang Cai Jing·2026-02-23 13:28
Company News - Arcellx shares surged over 78% in pre-market trading as Gilead Sciences announced plans to acquire Arcellx at a price of $115 per share [1] - Novo Nordisk shares fell nearly 14% in pre-market trading due to clinical trial results showing that its product CagriSema was less effective than Eli Lilly's Zepbound [1]